Ask AI
ProCE Banner Activity

Interactive Treatment Decision Tool for MCL: A US Perspective

Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with MCL with those of 5 renowned experts from the United States.

Released: August 27, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Faculty Disclosure

Primary Author

Stephen M. Ansell, MD, PhD: researcher: ADC Therapeutics, AstraZeneca, Bristol Myers Squibb, Enterome, Pfizer, Regeneron, Step Pharma, Takeda. 

Ian Flinn, MD, PhD: consultant/advisor/speaker: AbbVie, BeiGene, Genentech, Genmab, Kite, Vicerx; researcher: 2SeventyBio, AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Celgene, Epizyme, Fate, Genentech, Gilead Sciences, IGM Biosciences, Innocare, Incyte, Janssen, Kite, Loxo, Marker Therapeutics, Merck, Morphosys, Myeloid Therapeutics, Novartis, Nurix, Pfizer, Roche, Seattle Genetics, TG Therapeutics, Vincerx.

Brad Kahl, MD: consultant/advisor/speaker: AbbVie, ADCT, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Lilly, Merck, Pfizer, Roche.

Tycel J. Phillips, MD: consultant/advisor/speaker: AbbVie, Adaptive, ADCT, AstraZeneca, Bayer, BeOne, Bristol Myers Squibb, Caribou, Epizyme, Genentech, Genmab, Incyte, Ipsen, Johnson & Johnson, Janssen, Kite/Gilead, Lilly, Merck, Pharmacyclics, Pfizer, Regeneron, Sobi, Xencor; researcher: AbbVie, Bristol Myers Squibb, Genentech, Sobi.

Julie M. Vose, MD, MBA: consultant/advisor/speaker: AbbVie, AstraZeneca, GenMab, Lilly.